PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-05-22

Date Title Company
22-May-2019 Federal judge enters consent decree against compounder PharMedium Services for violations at multiple facilities U.S. Food and Drug Administration
22-May-2019 MorphoSys AG Reports Outcome of Annual General Meeting 2019 (news with additional features) MorphoSys AG
22-May-2019 New Exploratory Data from VARSITY, the First Prospective Head-to-Head Ulcerative Colitis Biologic Trial Which Demonstrated Superiority of Vedolizumab to Adalimumab in Clinical Remission at Week 52, Presented at 2019 Digestive Disease Week® Takeda UK Ltd
22-May-2019 EMC Szpitale, Poland, brings access to innovative treatments to its patients by joining Clinerion’s Patient Network Explorer platform. LifeArc
22-May-2019 LifeArc monetises Keytruda® (pembrolizumab) royalty interests to fund further research and investment LifeArc
22-May-2019 SOTIO to Present Final Phase I/II DCVAC/LuCa Data at ASCO 2019 Annual Meeting SOTIO
22-May-2019 New Post-hoc Analysis Shows Adding UPTRAVI®▼ (selexipag) Versus Placebo Improved Long-Term Clinical Outcomes Regardless of Time of Treatment Initiation, and Demonstrated an Even More Pronounced Treatment Effect When Initiated Early Actelion
22-May-2019 A SMARTPHONE SCREENING TEST FOR CHRONIC KIDNEY DISEASE WHICH WILL SAVE LIVES AND HUNDREDS OF MILLIONS OF POUNDS Syncona
22-May-2019 Syncona founds Quell Therapeutics with £35 million Series A Financing Syncona
22-May-2019 Promising Clinical Data from Pilot Study of Gelesis’ Novel Hydrogel GS500 Prototype for the Potential Treatment of Chronic Constipation Presented at Digestive Disease Week by Researchers from Massachusetts General Hospital and Brigham and Women’s Hospital PureTech Health
22-May-2019 Symphogen publishes discovery and pre-clinical data on first chicken-derived antibody to enter human clinical trials Symphogen
22-May-2019 First patient treated in DIAMOND study to evaluate if Veltassa® (patiromer) improves outcomes by enabling long-term use of essential RAASi therapy Vifor Pharma
22-May-2019 Abeona Therapeutics Announces FDA Clearance of Investigational New Drug Application for ABO-202 Gene Therapy in CLN1 Disease Abeona Therapeutics
22-May-2019 Santhera Starts Collaboration in Gene Therapy Research for Congenital Muscular Dystrophy with the Biozentrum, University of Basel, Co-Financed by Innosuisse Santhera
22-May-2019 Sofinnova Partners Launch MD Start III Medtech Acceleration Fund at €48M Sofinnova
22-May-2019 GamaMabs Pharma to present updated results at 2019 ASCO Annual Meeting from the First-In-Human clinical study of murlentamab in advanced gynecological cancers GamaMabs Pharma
22-May-2019 CO.DON AG: Capital increase completed successfully CO.DON AG
22-May-2019 Worldwide Addiction Treatment Market By Product, Distribution, End User and Forecast to 2028 Wired Release
22-May-2019 Interstitial Lung Disease (ILD) Experts And Advocates Announce Formation Of Open Source Imaging Consortium (OSIC) Open Source Imaging Consortium (OSIC)
22-May-2019 Worldwide Vitamin E Market Strategic Assessment and Forecast 2019-2028 Wired Release